ArticleMolecules (Basel, Switzerland)2025
Disubstituted Meldrum's Acid: Another Scaffold with SuFEx-like Reactivity.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial on the Advances in Organic Synthesis in Pharmaceuticals, Agrochemicals and Materials.Molecules (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Sulfur Fluoride Exchange (SuFEx) chemistry represents an emerging class of click reactions that has found broad applications in drug discovery and materials science. Traditionally, SuFEx reactivity has been regarded as the exclusive privilege of sulfur and fluorine. Accordingly, the scaffolds exhibiting SuFEx-like reactivity without sulfur or fluorine have remained underdeveloped. Indeed, SuFEx reactions may represent a more generalizable mode of chemical reactivity. By enhancing the electrophilicity of the carbonyl group and increasing the steric hindrance around the carbon center, we identified disubstituted Meldrum's acid as a novel carbon-based scaffold with SuFEx-like reactivity. Various O-, S-, and N-nucleophiles are viable exchange partners in the presence of Barton's base or DBU. In addition to the original method, a catalytic protocol was developed and successfully applied to drug derivatization, including the gram-scale modification of acetaminophen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.